Cardiometabolic risk factors and their relationship with the interleukin-6 receptor gene polymorphism (rs2228145) in patients with hypertrophic cardiomyopathy by T. G. Bezhanishvili, A. Ya. Gudkova, V. G. Davydova, S. E. Andreeva, A. N. Krutikov, E. N. Semernin, B. N. Kudryavtsev, S. A. Pyko, A. A. Kostareva, E. N. Shlyakhto

Subjects: Get full text

IL-6 Signaling in Immunopathology: From Basic Biology to Selective Therapeutic Intervention by Schumertl T, Lokau J, Garbers C

Subjects: “…Interleukin-6…”
Get full text

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6) by E. L. Nasonov, E. Feist

Subjects: Get full text

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6 by Evgeny L. Nasonov, Azamat M. Satybaldyev, Elvira N. Otteva, Tatiana V. Beketova, Andrey A. Baranov

Subjects: Get full text

Comparison of inhalation and total intravenous anesthesia on inflammatory markers in microdiscectomy: a double-blind study by Merve Bulun Yediyıldız, İrem Durmuş, Hülya Yılmaz Ak, Kübra Taşkın, Mikail Adem Devrüş Ceylan, Yücel Yüce, Banu Çevik, Evren Aydoğmuş

Subjects: Get full text

Role of myokines in regulation of a power exchange by V. I. Scherbakov, G. A. Skosyreva, T. I. Ryabichenko

Subjects: Get full text

Nano-curcumin Effects on Ischemic Stroke clinical outcomes and Interleukin-6 Levels: Pilot Randomized Clinical Trial by Zeinab Ehtiatkar, Alia Saberi, Samaneh Ghorbani Shirkouhi, Mozaffar Hosseininezhad, Shahrokh Yousefzadeh-Chabok, Yaser Moadabi, Ashkan Karimi, Haniyeh Shadrou Gharani, Sasan Andalib

Subjects: Get full text

Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection by Juliane Lokau, Juliane Lokau, Yvonne Garbers, Manuel M. Vicente, Anna Dittrich, Stefan Meltendorf, Holger Lingel, Anja K. Münster-Kühnel, Monika Brunner-Weinzierl, Christoph Garbers, Christoph Garbers

Subjects: “…interleukin-6…”
Get full text

Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer by Ema Mitsui, Satoru Kikuchi, Tomohiro Okura, Hiroshi Tazawa, Yuta Une, Noriyuki Nishiwaki, Shinji Kuroda, Kazuhiro Noma, Shunsuke Kagawa, Toshiaki Ohara, Junko Ohtsuka, Rieko Ohki, Toshiyoshi Fujiwara

Subjects: Get full text

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase I... by E. L. Nasonov, M. L. Stanislav, T. A. Raskina, G. V. Kuropatkin, I. V. Shirinsky, A. P. Rebrov, N. A. Shostak, B. A. Alikhanov, E. N. Ushakov, R. G. Kamalova, S. A. Smakotina, V. I. Simanenkov, A. S. Pavsun, I. I. Zaharjan, S. S. Yakushin, M. Yu. Sandin

Subjects: Get full text

Leptin and Iinterlukin-6 relationship and influence of mortality in sepsis by Yi-Hsuan Tsai, Kai-Yin Hung, Wen-Feng Fang

Subjects: Get full text

INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE by T. V. Beketova, E. L. Nasonov

Subjects: Get full text

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence by E. L. Nasonov, A. M. Lila

Subjects: Get full text

Tocilizumab: A potent immunomodulatory agent in the treatment of COVID-19 pneumonia by Sameer Bansal, Uma Karjigi, Ravindra M Mehta

Subjects: Get full text

Clinical case of olokizumab treatment in a patient with diffuse systemic sclerosis by E. S. Kuvardin, D. Yu. Andreev, P. A. Yastrebov, V. Yu. Myachikova, D. V. Bukhanova, D. V. Karpova, K. N. Malikov, M. Yu. Samsonov, A. L. Maslyanskiy

Subjects: Get full text

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES by E. L. Nasonov, A. M. Lila

Subjects: Get full text

The role of interleukin-6 classic and trans-signaling and interleukin-11 classic signaling in gastric cancer cells by Josephine Runge, Christoph Garbers, Juliane Lokau

Subjects: “…interleukin-6…”
Get full text

Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders by T. A. Lisitsyna, D. Yu. Veltishchev, A. M. Lila, E. L. Nasonov

Subjects: “…interleukin 6…”
Get full text

Balance Exercises as a Fundamental Aspect of Functional Recovery in patients with Knee Osteoarthritis: A Systematic Review by Trishna Kakati, Swapnav Borthakur

Subjects: “…interleukin-6…”
Get full text

PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS by L. P. Ananyeva

Subjects: Get full text